Form 4 for DGX Quest Diagnostics
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001022079-26-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F - Tax | $204.86 | -205 | 9,869 | -2% | -$42.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | F | D | 205 | $204.86 | 9,869 | D | — | — | (F1) Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. (F2) The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. |